961 related articles for article (PubMed ID: 29428479)
21. Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy.
Adachi K; Tamada K
Cancer Sci; 2015 Aug; 106(8):945-50. PubMed ID: 25981182
[TBL] [Abstract][Full Text] [Related]
22. [Immune system and tumors].
Terme M; Tanchot C
Ann Pathol; 2017 Feb; 37(1):11-17. PubMed ID: 28159405
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment.
Spranger S
Int Immunol; 2016 Aug; 28(8):383-91. PubMed ID: 26989092
[TBL] [Abstract][Full Text] [Related]
24. "Tumor immunology meets oncology (TIMO) XII", April 28th-30th 2016, Halle/Saale, Germany.
Seliger B
Cancer Immunol Immunother; 2017 Nov; 66(11):1497-1503. PubMed ID: 28695228
[No Abstract] [Full Text] [Related]
25. Can calcium signaling be harnessed for cancer immunotherapy?
Rooke R
Biochim Biophys Acta; 2014 Oct; 1843(10):2334-40. PubMed ID: 24524821
[TBL] [Abstract][Full Text] [Related]
26. Scientific contributions toward successful cancer immunotherapy in The Netherlands.
Melief CJ; Scheper RJ; de Vries IJ
Immunol Lett; 2014 Dec; 162(2 Pt B):121-6. PubMed ID: 25455598
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapy of cancer: reprogramming tumor-immune crosstalk.
Payne KK; Toor AA; Wang XY; Manjili MH
Clin Dev Immunol; 2012; 2012():760965. PubMed ID: 23097673
[TBL] [Abstract][Full Text] [Related]
28. Immuno-oncology from the perspective of somatic evolution.
González S; Volkova N; Beer P; Gerstung M
Semin Cancer Biol; 2018 Oct; 52(Pt 2):75-85. PubMed ID: 29223477
[TBL] [Abstract][Full Text] [Related]
29. The Role of mRNA Translational Control in Tumor Immune Escape and Immunotherapy Resistance.
Cerezo M; Robert C; Liu L; Shen S
Cancer Res; 2021 Nov; 81(22):5596-5604. PubMed ID: 34470777
[TBL] [Abstract][Full Text] [Related]
30. Immunomodulatory effects of current cancer treatment and the consequences for follow-up immunotherapeutics.
Mooradian MJ; Sullivan RJ
Future Oncol; 2017 Aug; 13(18):1649-1663. PubMed ID: 28776423
[TBL] [Abstract][Full Text] [Related]
31. Immune escape mechanisms as a guide for cancer immunotherapy.
Beatty GL; Gladney WL
Clin Cancer Res; 2015 Feb; 21(4):687-92. PubMed ID: 25501578
[TBL] [Abstract][Full Text] [Related]
32. ILT4 functions as a potential checkpoint molecule for tumor immunotherapy.
Gao A; Sun Y; Peng G
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):278-285. PubMed ID: 29649510
[TBL] [Abstract][Full Text] [Related]
33. Adaptive Immune Resistance: How Cancer Protects from Immune Attack.
Ribas A
Cancer Discov; 2015 Sep; 5(9):915-9. PubMed ID: 26272491
[TBL] [Abstract][Full Text] [Related]
34. Targeting natural killer cells in cancer immunotherapy.
Guillerey C; Huntington ND; Smyth MJ
Nat Immunol; 2016 Aug; 17(9):1025-36. PubMed ID: 27540992
[TBL] [Abstract][Full Text] [Related]
35. Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor Microenvironment.
Gajewski TF; Corrales L; Williams J; Horton B; Sivan A; Spranger S
Adv Exp Med Biol; 2017; 1036():19-31. PubMed ID: 29275462
[TBL] [Abstract][Full Text] [Related]
36. Immune Cell-Derived Exosomes in the Cancer-Immunity Cycle.
Yan W; Jiang S
Trends Cancer; 2020 Jun; 6(6):506-517. PubMed ID: 32460004
[TBL] [Abstract][Full Text] [Related]
37. Cancer Epigenetics, Tumor Immunity, and Immunotherapy.
Cao J; Yan Q
Trends Cancer; 2020 Jul; 6(7):580-592. PubMed ID: 32610068
[TBL] [Abstract][Full Text] [Related]
38. [Which future for B lymphocytes infiltrating solid tumors: prognostic biomarker and/or therapeutic target?].
Kaplon H; Dieu-Nosjean MC
Med Sci (Paris); 2018 Jan; 34(1):72-78. PubMed ID: 29384099
[TBL] [Abstract][Full Text] [Related]
39. Fibroblasts Fuel Immune Escape in the Tumor Microenvironment.
De Jaeghere EA; Denys HG; De Wever O
Trends Cancer; 2019 Nov; 5(11):704-723. PubMed ID: 31735289
[TBL] [Abstract][Full Text] [Related]
40. Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients.
Sabbatino F; Liguori L; Polcaro G; Salvato I; Caramori G; Salzano FA; Casolaro V; Stellato C; Col JD; Pepe S
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
